Investigates how protamine affects fluorescence in sperm DNA, suggesting its role in DNA binding.
In this study we investigated the relationship between the presence of bound protamine on mouse and human sperm DNA and the level of chromomycin A(3) (CMA(3)) and 4'6-diamidino-2-phenylindole (DAPI) fluorescence. This was accomplished by performing a competition assay between salmon protamine and fluorochromes on decondensed spermatozoa that had their nuclear proteins extracted and were fixed on slides. Various concentrations (0, 0.005, 0.0225, 0.05, 0.225, 0.5 and 5 mg/ml) of salmon protamine were added to either the CMA, or DAPI staining solutions. Fluorescence emission measurements of stained sperm nuclei were then performed using a microfluorometer. When the treated decondensed sperm heads were stained with either CMA(3) or DAPI all spermatozoa were found to fluoresce intensely. The addition of protamines to the spermatozoa led to an elimination of CMA(3) fluorescence, while the intensity of DAPI staining was decreased to similar to 50% at the highest concentrations of protamine. The addition of increasing amounts of salmon protamine also induced the sperm nuclei to regain their initial condensed appearance. This study shows that protamine retains a strong affinity for sperm DNA in situ and that CMA(3) fluorescence is a strong indicator of the protamination state of spermatozoa.
No takes yet. Share an insight, caveat, or question.
D et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: